FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2268677495> ?p ?o ?g. }

• W2268677495 endingPage "203" @default.
• W2268677495 startingPage "195" @default.
• W2268677495 abstract "Twenty-nine patients with systemic lupus erythematosus were treated with a new synthetic unsaturated prednisolone derivative, triamcinolone, for as long as 11 months. This hormone is 1.3 times as powerful as prednisone and 4.4 times more potent than hydrocortisone as an anti-inflammatory agent. The average dose for beginning therapy in cases of mild systemic lupus erythematosus was 20.6 mg. a day. The average maintenance dose used to control mild exacerbations of the disease was 26.0 mg. a day. There was no evidence of sodium retention or potassium loss. Sixteen patients had upper gastrointestinal x-ray studies before and during therapy with triamcinolone. There was no evidence of peptic ulceration except in one patient who was receiving 96 mg. a day. Nine patients had gastric analysis with histamine before and during therapy. No significant changes were noted in results of these tests, even in the patient who had an ulcer. No abnormal increase in uropepsin was noted in cases in which this factor was tested. The pattern of clinical improvement closely paralleled that obtained by previous treatment with older steroids. There was a disappearance of all the clinical and laboratory abnormalities produced by the disease, with the exception of long standing renal involvement. A major difference between triamcinolone and other steroids was a tendency to progressive gradual loss of weight, partly owing to fluid loss. Cushingoid appearance produced by other steroid therapy did not disappear. The cutaneous side effects, particularly Cushingoid appearance, hirsutism and striae were more pronounced than with older steroids. The most serious side effect was muscle weakness which appeared in six patients, all women, in from four to thirty-two weeks after starting triamcinolone. The profound muscle weakness, most pronounced in the quadriceps group, gradually cleared after several weeks of therapy with another steroid. Fourteen patients had received prior steroid therapy with all the older anti-inflammatory hormones and seven of them were better controlled and felt better with triamcinolone." @default.
• W2268677495 created "2016-06-24" @default.
• W2268677495 creator A5086135843 @default.
• W2268677495 date "1958-09-01" @default.
• W2268677495 modified "2023-09-23" @default.
• W2268677495 title "Systemic lupus erythematosus; results of treatment with triamcinolone." @default.
• W2268677495 cites W1580758731 @default.
• W2268677495 cites W2004978327 @default.
• W2268677495 cites W2019113395 @default.
• W2268677495 cites W2046411702 @default.
• W2268677495 cites W2234213639 @default.
• W2268677495 cites W2412049408 @default.
• W2268677495 cites W2414868773 @default.
• W2268677495 cites W41702405 @default.
• W2268677495 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1512469" @default.
• W2268677495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13573187" @default.
• W2268677495 hasPublicationYear "1958" @default.
• W2268677495 type Work @default.
• W2268677495 sameAs 2268677495 @default.
• W2268677495 citedByCount "2" @default.
• W2268677495 crossrefType "journal-article" @default.
• W2268677495 hasAuthorship W2268677495A5086135843 @default.
• W2268677495 hasConcept C126322002 @default.
• W2268677495 hasConcept C141071460 @default.
• W2268677495 hasConcept C159654299 @default.
• W2268677495 hasConcept C16005928 @default.
• W2268677495 hasConcept C203014093 @default.
• W2268677495 hasConcept C2775915377 @default.
• W2268677495 hasConcept C2776715498 @default.
• W2268677495 hasConcept C2776804153 @default.
• W2268677495 hasConcept C2778720950 @default.
• W2268677495 hasConcept C2778903070 @default.
• W2268677495 hasConcept C2909029107 @default.
• W2268677495 hasConcept C71924100 @default.
• W2268677495 hasConcept C90924648 @default.
• W2268677495 hasConceptScore W2268677495C126322002 @default.
• W2268677495 hasConceptScore W2268677495C141071460 @default.
• W2268677495 hasConceptScore W2268677495C159654299 @default.
• W2268677495 hasConceptScore W2268677495C16005928 @default.
• W2268677495 hasConceptScore W2268677495C203014093 @default.
• W2268677495 hasConceptScore W2268677495C2775915377 @default.
• W2268677495 hasConceptScore W2268677495C2776715498 @default.
• W2268677495 hasConceptScore W2268677495C2776804153 @default.
• W2268677495 hasConceptScore W2268677495C2778720950 @default.
• W2268677495 hasConceptScore W2268677495C2778903070 @default.
• W2268677495 hasConceptScore W2268677495C2909029107 @default.
• W2268677495 hasConceptScore W2268677495C71924100 @default.
• W2268677495 hasConceptScore W2268677495C90924648 @default.
• W2268677495 hasIssue "3" @default.
• W2268677495 hasLocation W22686774951 @default.
• W2268677495 hasOpenAccess W2268677495 @default.
• W2268677495 hasPrimaryLocation W22686774951 @default.
• W2268677495 hasRelatedWork W12352464 @default.
• W2268677495 hasRelatedWork W155493133 @default.
• W2268677495 hasRelatedWork W1970685406 @default.
• W2268677495 hasRelatedWork W2005299726 @default.
• W2268677495 hasRelatedWork W2008282647 @default.
• W2268677495 hasRelatedWork W2012711233 @default.
• W2268677495 hasRelatedWork W2023514659 @default.
• W2268677495 hasRelatedWork W2057792631 @default.
• W2268677495 hasRelatedWork W2268677495 @default.
• W2268677495 hasRelatedWork W244029028 @default.
• W2268677495 hasVolume "89" @default.
• W2268677495 isParatext "false" @default.
• W2268677495 isRetracted "false" @default.
• W2268677495 magId "2268677495" @default.
• W2268677495 workType "article" @default.